Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.

Profile Publications (6)
XB-PERS-711

Publications By Tod Woolf

???pagination.result.count???

???pagination.result.page??? 1


In vitro model systems to investigate bile salt export pump (BSEP) activity and drug interactions: A review., Cheng Y, Woolf TF, Gan J, He K., Chem Biol Interact. August 5, 2016; 255 23-30.


Toward the therapeutic editing of mutated RNA sequences., Woolf TM, Chase JM, Stinchcomb DT., Proc Natl Acad Sci U S A. August 29, 1995; 92 (18): 8298-302.


Expression of activin mRNA during early development in Xenopus laevis., Dohrmann CE, Hemmati-Brivanlou A, Thomsen GH, Fields A, Woolf TM, Melton DA., Dev Biol. June 1, 1993; 157 (2): 474-83.   


Specificity of antisense oligonucleotides in vivo., Woolf TM, Melton DA, Jennings CG., Proc Natl Acad Sci U S A. August 15, 1992; 89 (16): 7305-9.


Activins are expressed early in Xenopus embryogenesis and can induce axial mesoderm and anterior structures., Thomsen G, Woolf T, Whitman M, Sokol S, Vaughan J, Vale W, Melton DA., Cell. November 2, 1990; 63 (3): 485-93.


The stability, toxicity and effectiveness of unmodified and phosphorothioate antisense oligodeoxynucleotides in Xenopus oocytes and embryos., Woolf TM, Jennings CG, Rebagliati M, Melton DA., Nucleic Acids Res. April 11, 1990; 18 (7): 1763-9.

???pagination.result.page??? 1